Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Sleep in Autistic Children
NCT01993251Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of melatonin in sleep disorder (4 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Number of nocturnal awakenings at Day 29. Started Jun 2014; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT01993251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993251.